By [Your Name/Journalistic Staff], based on insights from Jana Wu, LCSW, LADC, ICAADC, CASAC
For over 15 years, Jana Wu has sat across from patients in the trenches of mental health and substance use treatment. As she approaches 50, a profound, systemic question has begun to overshadow her clinical practice: Why is the healthcare establishment so eager to suppress women’s distress before we have even begun to understand its origin?
This inquiry has been brought into sharp focus by the rise of kratom—a tropical tree leaf from Southeast Asia that has quietly become a staple in the medicine cabinets of women in their late 30s through their 60s. For these women, kratom is rarely a recreational indulgence; it is a tactical tool used to navigate the relentless demands of midlife. However, as the medical community grapples with this trend, it reveals a hauntingly familiar pattern in how society treats the female experience of anxiety.
The Chronology of Medicalized Distress
To understand the current reliance on kratom, one must look at the historical trajectory of how female anxiety has been managed—and often dismissed—by the medical establishment.
The 19th Century: Hysteria and Neurasthenia
In the 1800s, the medical response to female distress was rooted in patriarchal diagnostic labels. "Hysteria" and "neurasthenia" became catch-all terms for women suffering from fatigue, insomnia, irritability, and chronic pain. These diagnoses were rarely about uncovering the root cause of the distress; they were about categorizing the "unmanageable" woman and seeking a way to quiet her symptoms.
The Mid-20th Century: The Age of the Tranquilizer
By the 1950s and 60s, the chemical landscape shifted. Sedatives and tranquilizers—most notably Miltown—hit the market, promising a quick fix for the pressures of domestic life. In 1963, Valium was introduced, eventually becoming the most prescribed medication in the United States.
The cultural ubiquity of these drugs was cemented in 1966 by The Rolling Stones’ hit, "Mother’s Little Helper," which chronicled the daily chemical maintenance required by a housewife to keep up with the pressures of family, aging, and societal expectations. Nearly 60 years later, the prescription pads have changed, but the fundamental issue remains: when the external pressures of a woman’s life do not subside, the medicalized "relief" becomes a permanent, and often dangerous, fixture.
The Midlife Crucible: Why Kratom?
Today, women in midlife face a unique convergence of stressors. Perimenopause introduces hormonal volatility, manifesting as sleep disruption, mood swings, and spikes in anxiety. Simultaneously, this demographic is often caught in the "sandwich generation" trap—managing high-pressure careers while caring for both children and aging parents.
When traditional systems fail to address this holistic exhaustion, many women stumble upon kratom. They report that it provides not just relief from anxiety, but a functional boost—a way to maintain the "superwoman" facade required by their daily lives.
The "Natural" Fallacy
For many, kratom represents an attempt to reclaim autonomy. By choosing a substance perceived as "natural" and "traditional," women are often attempting to step outside the pharmaceutical system that they feel has failed to hear them. However, as clinicians warn, "natural" is not synonymous with "safe" or "predictable."
Because kratom is not regulated by the FDA, potency varies wildly. Furthermore, the lack of standardized dosing means that what begins as a quest for energy or calm can quickly spiral into physical dependence.
Supporting Data and Clinical Implications
The clinical reality of kratom usage is often obscured by the fact that patients rarely use it in isolation.
The Danger of Polysubstance Use
One of the most pressing concerns for modern addiction specialists is the prevalence of polysubstance use. Data suggests that individuals using kratom are frequently combining it with alcohol, prescribed benzodiazepines, or opioids.
- Respiratory Depression: The combination of kratom with other sedating agents significantly increases the risk of respiratory depression—a life-threatening condition where breathing becomes dangerously slow.
- The Withdrawal Cycle: Like benzodiazepines, kratom is associated with its own withdrawal syndrome. Patients who begin using it to "function" often find themselves trapped in a cycle of needing the substance just to reach a baseline level of normalcy.
The Failure of Symptom Suppression
The healthcare system is currently optimized for "symptom management" rather than "root-cause investigation." When a woman presents with sudden insomnia or panic, the clinical instinct is often to offer a prescription to make the symptom disappear.
However, Jana Wu argues that true care requires curiosity. Does this woman’s anxiety stem from a hormonal shift? A toxic workplace? An undiagnosed trauma? Or is it a natural reaction to an unsustainable life? By rushing to offer relief, providers may inadvertently participate in a cycle that treats the woman’s reaction to her life as the primary pathology, rather than addressing the life itself.
Whose Discomfort Are We Treating?
Perhaps the most uncomfortable question a healthcare provider can ask is: "Whose discomfort are we actually treating?"
Often, the medication is provided because the provider—or the patient’s family or employer—is uncomfortable with the woman’s distress. By medicating the anxiety, we ensure the woman remains productive, silent, and "functional." We prioritize the maintenance of the status quo over the patient’s long-term health and emotional processing.
The Need for a New Paradigm
Transitioning away from a reliance on "relief" requires a multi-pronged approach:
- Comprehensive Screening: Providers must look beyond the immediate symptom. If a woman in her 40s or 50s reports new-onset anxiety, a thorough medical review (including hormonal health) and a psychosocial assessment are mandatory.
- Harm Reduction and Education: Because kratom use is widespread, clinicians must be educated on how to discuss it without shame. Open dialogue allows for honest conversations about the risks of polysubstance use and the potential for dependence.
- Holistic Treatment Plans: We must offer women more than a binary choice between enduring severe distress and relying on a substance. Therapy, lifestyle adjustments, hormonal support, and, when necessary, carefully monitored medication should be part of a broader, long-term wellness strategy.
The Path Forward
The narrative of the "stressed-out woman" seeking relief is as old as the medical profession itself. Whether it was the "hysteria" of the 19th century, the Valium of the 1960s, or the kratom of today, the underlying drive is the same: women are looking for a way to survive the impossible expectations placed upon them.
As clinicians and society at large learn more about kratom and the modern rise of substance use disorders in women, we must listen to the stories behind the symptoms. Sometimes, that story began years earlier with a woman who was simply trying to keep her head above water, and a provider who was too quick to offer a quick fix.
The challenge for the next generation of mental health care is not to provide more efficient ways to mask distress, but to create a culture that allows women the space to feel, express, and ultimately resolve the pressures of their lives without the need for a "little helper."
About the Contributor:
Jana Wu, LCSW, LADC, ICAADC, CASAC, is a clinician at Mountainside Treatment Center. A nationally recognized expert on kratom, she founded the country’s first clinician-led kratom support group. Her work focuses on PTSD, anxiety, and the complex, often-overlooked intersections of women’s health and substance use.
